bioihbjkbjnl/mcl2 huggingface dataset:
Exparel Use in Adductor Canal Block After Total Knee Arthroplasty
Condition: Arthritis Knee; Pain, Postoperative; Opioid Use
MeSH terms: Pain, Postoperative
Intervention: Exparel; Ropivacaine
Intervention description: Exparel used in Adductor Canal Block plus Infiltration Between Popliteal Artery and Capsule of Knee using Ropivacaine; Ropivacaine used in Adductor Canal Block plus Infiltration Between Popliteal Artery and Capsule of Knee using Ropivacaine
Intervention MeSH terms: Ropivacaine
Phase: Phase 3
Study type: Interventional
Primary purpose: Treatment
Allocation: Randomized
Intervention model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Enrollment: 100.0
Sex: All
Minimum age: 18 Years
Maximum age: 99 Years
Healthy volunteers: Accepts Healthy Volunteers
Keywords: Exparel; adductor; knee; arthroplasty; opioid

Summary:

      Exparel has been shown to have better pain control compared to previously used infiltration
      agents, including bupivacaine, while having a minor side effect profile. The purpose of this
      study is to explore the effectiveness of Exparel (liposomal bupivacaine) in Adductor Canal
      Blocks for peri-operative pain control following a total knee arthroplasty (TKA) procedure.
    

Eligibility criteria:

        Inclusion Criteria:

          -  Patients were eligible for inclusion if they were undergoing unilateral primary TKA
             for a diagnosis of knee osteoarthritis and were not undergoing any additional
             concomitant procedures were.

        Exclusion Criteria:

          -  Patients were not eligible for our study if they were undergoing revision TKA, if they
             were undergoing bilateral TKA or concomitant procedures, or if they had an active
             infection.